Open access · CC-BY
via OpenAlex
Tissue deconjugation of urolithin A glucuronide to free urolithin A in systemic inflammation
M. A. Ávila-Gálvez, Juan Antonio Giménez‐Bastida, Antonio González‐Sarrías, Juan Carlos Espı́n
Food & Function · 2019 · ▲ 59 citations
Abstract
Urolithin A (Uro-A) is an anti-inflammatory and cancer chemopreventive metabolite produced by the gut microbiota from the polyphenol ellagic acid. However, in vivo conjugation of Uro-A to Uro-A glucuronide (Uro-A glur) dramatically hampers its activity. We describe here for the first time the tissue deconjugation of Uro-A glur to Uro-A after lipopolysaccharide (LPS)-induced inflammation, which could explain the systemic in vivo activity of free Uro-A in microenvironments subjected to inflammatory stimuli.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1039/c9fo00298g
- Canonical
- link ↗
- Fetched
- 2026-06-24 MST
Cite this
APA
Ávila-Gálvez, M.A., Giménez‐Bastida, J.A., González‐Sarrías, A., & Espı́n, J.C. (2019). Tissue deconjugation of urolithin A glucuronide to free urolithin A in systemic inflammation. <em>Food & Function</em>. https://doi.org/10.1039/c9fo00298g
Vancouver
Ávila-Gálvez MA, Giménez‐Bastida JA, González‐Sarrías A, Espı́n JC. Tissue deconjugation of urolithin A glucuronide to free urolithin A in systemic inflammation. Food & Function. 2019. doi:10.1039/c9fo00298g.
BibTeX
@article{m2019Tissue,
title = {Tissue deconjugation of urolithin A glucuronide to free urolithin A in systemic inflammation},
author = {M. A. Ávila-Gálvez and Juan Antonio Giménez‐Bastida and Antonio González‐Sarrías and Juan Carlos Espı́n},
journal = {Food & Function},
year = {2019},
doi = {10.1039/c9fo00298g},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
CHEST Journal 2020
Citation only
Senotherapy
Mayo Clinic Proceedings 2011
Open access · OA
Regenerative Medicine: On the Vanguard of Health Care
Frontiers in Microbiology 2018
Open access · CC-BY
The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
EBioMedicine 2023
Open access · OA
Gut microbiota and its metabolites in depression: from pathogenesis to treatment
Biomedicines 2021
Open access · CC-BY
Immunomodulatory Role of Urolithin A on Metabolic Diseases
Annual Review of Medicine 2017
Open access · OA